Skip to main content

Roundup Deal: Plaintiffs Raise Concerns; Judge Casts Doubt

Roundup Deal: Plaintiffs Raise Concerns; Judge Casts Doubt

Roundup Deal: Plaintiffs Raise Concerns; Judge Casts Doubt

Introduction

On Thursday, U.S. District Judge Vince Chhabria, overseeing the Roundup multidistrict litigation docket, indicated that he might lift the stay on litigation after hearing concerns from plaintiffs' attorneys over the uncertainty of the more than $10 billion deal.

In June, the German chemical and pharmaceutical giant, Bayer, indicated that it would pay more than $10 billion to settle about 75% of the lawsuits claiming that its herbicide Roundup was the cause of non-Hodgkin’s lymphoma. Following the announcement of the deal, which is managed by mediator Kenneth Feinberg, Judge Chhabria halted the multidistrict litigation for the settlement process.

In July, Judge Chhabria had raised concerns over one part of the deal, which includes a plan for handling future claims brought by the consumers who develop non-Hodgkin’s lymphoma, after using the weedkiller. He indicated that he is skeptical of the propriety and fairness of the proposed settlement, and is tentatively inclined to deny the motion.

In the recent hearing, Judge Chhabria stated that he received several confidential letters alleging the manufacturer of reneging on its deal with the plaintiffs. After hearing arguments from both parties, he concluded that he would not lift the stay expressing his confidence in Feinberg’s ability to reach a resolution in 30 days. But he also noted that the parties should also start reworking on getting the litigation back on track as he won't extend the stay any further. The parties have been asked to be prepared by the next case management conference that is scheduled for September 24.

Roundup, one of the most commonly and widely used weedkillers, contains Glyphosate as one of its main ingredients. Glyphosate is a systemic and broad-spectrum herbicide that was patented by a U.S. company, Monsanto, in 1970. Bayer acquired Monsanto on June 7, 2018.

Currently, Bayer is facing more than 125,000 Roundup lawsuits, and the company has acknowledged the filing of 52,500 lawsuits. The lawsuits are consolidated under MDL No. 2741 in the U.S. District Court for the Northern District of California.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest News

title demo for news

Categories: Settlements

created dropdown in quarterly-results page in localy, and explore all the component codes 

Zantac Settles 4,000 Lawsuits in U.S. Courts

Categories: General

Sanofi has announced a settlement agreement regarding approximately 4,000 Zantac cancer lawsuits filed in state courts across the country.

Valsartan Recall Lawsuit Set for Trial

Categories: General

Years after the initiation of Valsartan recalls, the U.S. District Judge overseeing lawsuits filed by individuals harmed by tainted versions of…

Our Legal Drafting Services    
start @ $25 per hour.